A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

BACKGROUND: Haematopoietic stem cell transplantation (HSCT) has been tried in the last 15 years as a therapeutic option in patients with poor-prognosis autoimmune disease who do not respond to conventional treatments. Worldwide, more than 600 patients with multiple sclerosis (MS) have been treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Saccardi, R, Freedman, MS, Sormani, MP, Atkins, H, Farge, D, Griffith, LM, Kraft, G, Mancardi, GL, Nash, R, Pasquini, M, Martin, R, Muraro, PA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389500/
https://www.ncbi.nlm.nih.gov/pubmed/22383228
http://dx.doi.org/10.1177/1352458512438454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389500/
https://www.ncbi.nlm.nih.gov/pubmed/22383228
http://dx.doi.org/10.1177/1352458512438454

Ejemplares similares